XOMA (NASDAQ:XOMAO – Get Free Report) is expected to release its resultson Thursday, July 30th. Analysts expect XOMA to announce earnings of $0.1761 per share and revenue of $13.91 million for the quarter.
XOMA Stock Performance
Shares of NASDAQ XOMAO opened at $25.00 on Thursday. The stock’s fifty day simple moving average is $25.26 and its 200 day simple moving average is $25.36. XOMA has a 52-week low of $24.86 and a 52-week high of $26.40.
XOMA Announces Dividend
The business also recently announced a quarterly dividend, which was paid on Tuesday, July 14th. Shareholders of record on Thursday, July 2nd were paid a dividend of $0.5234 per share. The ex-dividend date of this dividend was Thursday, July 2nd. This represents a $2.09 dividend on an annualized basis and a dividend yield of 8.4%.
XOMA Company Profile
XOMA Corporation is a clinical-stage biotechnology company specializing in the discovery and development of therapeutic antibodies. The company applies its proprietary protein engineering and antibody optimization platform to generate novel drug candidates targeting autoimmune, inflammatory and metabolic diseases. XOMA’s scientific expertise spans antibody discovery, engineering, in vitro and in vivo testing, and early‐stage clinical development.
In addition to advancing its own pipeline of antibody candidates, XOMA collaborates with pharmaceutical and biotechnology partners to provide research and development services.
Featured Articles
- Five stocks we like better than XOMA
- Could Truth API Become Trump Media’s First Meaningful Revenue Driver?
- Small Caps Are Crushing the S&P 500—3 Stocks Still Worth Buying
- Moog Is More Than a Missile Maker, and Wall Street Is Noticing
- A Boring Dividend Growth Strategy Becomes a Solid Defensive Play
Receive News & Ratings for XOMA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for XOMA and related companies with MarketBeat.com's FREE daily email newsletter.
